147 related articles for article (PubMed ID: 287556)
1. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Trouet A; Sokal G
Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.
Ferrant A; Hulhoven R; Bosly A; Cornu G; Michaux JL; Sokal G
Cancer Chemother Pharmacol; 1979; 2(1):67-71. PubMed ID: 387279
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Marks TA; Venditti JM
Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
[TBL] [Abstract][Full Text] [Related]
4. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
Leverger G; Bancillon A; Schaison G
Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
[TBL] [Abstract][Full Text] [Related]
5. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
Wiernik PH
Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
[No Abstract] [Full Text] [Related]
6. [Survey of anthracyclines derivatives in haematology (author's transl)].
Jacquillat C; Weil M; Auclerc MF; Maral J; Schaison G; Boiron M; Bernard J
Nouv Presse Med; 1978 Jun; 7(23):2061-6. PubMed ID: 673774
[TBL] [Abstract][Full Text] [Related]
7. Clinical activity of detorubicin: a new anthracycline derivative.
Jacquillat C; Auclerc MF; Weil M; Maral J; Degos L; Auclerc G; Tobelem G; Schaison G; Bernard J
Cancer Treat Rep; 1979 May; 63(5):889-93. PubMed ID: 455330
[TBL] [Abstract][Full Text] [Related]
8. DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin.
Schwartz HS
Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):51-64. PubMed ID: 1124321
[TBL] [Abstract][Full Text] [Related]
9. The discovery of daunorubicin.
Di Marco A; Cassinelli G; Arcamone F
Cancer Treat Rep; 1981; 65 Suppl 4():3-8. PubMed ID: 7049379
[TBL] [Abstract][Full Text] [Related]
10. Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127).
Trouet A; de Duve C
Cancer Chemother Rep; 1975; 59(2 Pt 1):260. PubMed ID: 1149004
[No Abstract] [Full Text] [Related]
11. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
12. Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data.
Trouet A; Deprez-De Campeneere D
Cancer Chemother Pharmacol; 1979; 2(1):77-9. PubMed ID: 498424
[TBL] [Abstract][Full Text] [Related]
13. [Adriamycin in the treatment of acute infantile leukemia].
Massolo F; Galli V
Minerva Pediatr; 1973 May; 25(16):741-7. PubMed ID: 4592614
[No Abstract] [Full Text] [Related]
14. [Adriamycin in the treatment of acute infantile leukemia].
Massolo F; Galli V
Minerva Pediatr; 1973 May; 23(16):741-7. PubMed ID: 4581975
[No Abstract] [Full Text] [Related]
15. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
Svojgrová M; Slechtová J; Hůla J
Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
[TBL] [Abstract][Full Text] [Related]
16. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Davis HL; Davis TE
Cancer Treat Rep; 1979 May; 63(5):809-15. PubMed ID: 378369
[No Abstract] [Full Text] [Related]
17. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
Johnson RK; Chitnis MP; Embrey WM; Gregory EB
Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
[TBL] [Abstract][Full Text] [Related]
18. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin (NSC-123127) and its analogs.
Henry DW
Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
[No Abstract] [Full Text] [Related]
20. Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline.
Velu T; Debusscher L; Stryckmans P
Am J Hematol; 1988 Mar; 27(3):224-5. PubMed ID: 3162347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
